Shuhei Tomozawa

Fujita Health University

Papers

1

Total Citations

8

H-Index

1

About

Dr. Shuhei Tomozawa is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes in complex oncologic procedures, particularly robot-assisted radical cystectomy (iRARC). His primary research areas include enhanced recovery after surgery (ERAS) protocols, frailty assessment, and postoperative complication management in bladder cancer patients. Dr. Tomozawa’s most notable contribution is his 2024 study examining the impact of ERAS protocols on bowel recovery and postoperative ileus in frail patients undergoing iRARC with intracorporeal urinary diversion. This work, which has garnered 8 citations in a short time, demonstrates that structured recovery pathways can significantly benefit even the most vulnerable surgical populations. By addressing the intersection of frailty and perioperative care, Dr. Tomozawa provides actionable insights for reducing complications and improving recovery trajectories. His research is particularly valuable for surgeons and trainees seeking evidence-based strategies to enhance patient outcomes in high-risk urologic oncology cases. Through his focused investigations, Dr. Tomozawa continues to advance the field of minimally invasive urologic surgery and perioperative medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Impact of an enhanced recovery protocol in frail patients after intracorporeal urinary diversion
8 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Fujita Health University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago